摘要:
This invention relates to the use of aryl ureas in the manufacture of a medicament for treating or preventing diseases characterized by abnormal angiogenesis or hyperpermeability processes which are mediated by the VEGF induced signal transduction pathway.
摘要:
The present invention provides biomolecules and the use of these biomolecules for the differential diagnosis of epithelial cancers or an acute and chronic inflammation of the epithelium. In particular the present invention provides methods for detecting biomolecules within a test sample as well as a database comprising of mass profiles of biomolecules specific for healthy subjects, subjects having a precancerous lesion, subjects having an epithelial cancer or a metastasised epithelial cancer or subjects having an acute and chronic inflammation of the epithelium. Furthermore, the present invention provides methods for the characterization of said biomolecules using gas phase ion spectrometry. In addition, the present invention provides methods for the identification of said biomolecules provided that they are proteins or polypeptides. The invention further provides kits for the differential diagnosis of epithelial cancers or an acute and chronic inflammation of the epithelium.
摘要:
A soilless sod and a method of producing same are disclosed. The method comprises providing a growth mat with cotton and viscose fibers, providing grass seeds or grass sprigs to the growth mat, providing grass sprigs onto the growth mat, and providing a cover mat on top of the upper side of the growth mat. The soilless sod comprises a geo-textile mat being a growth mat, growing material consisting of any combination of grass seeds and grass sprigs, and a cover mat that is in touch with the upper side of the growth mat. The cover mat may be affixed to the growth mat by any of stitch bonding or punch needling or sewing or bonding.
摘要:
A sorting apparatus and method for directed sort combinatorial chemical synthesis is provided. This invention relates to a directed flexible, sorting apparatus and method for combinatorial chemical synthesis using a directed split and recombine process. The process utilizes one algorithm that is universal in directing and sorting a library of any size. This invention further provides a method of sorting solid supports for combinatorial chemical synthesis comprising delivering one or more supports which are organized in a one dimensional linear array in one or more reaction vessels, to an isolation and transfer chamber, transferring one or more support from each of said reaction vessels to one or more subsequent reaction vessels, in a patterned distribution; wherein the patterned distribution of supports in each subsequent transfer is identical and the position of each support in a reaction vessel codes for its previous synthesis history. In another aspect, the invention provides a directed sort apparatus wherein all members of a set at a given point in time are reacted with the same chemical building blocks throughout synthesis.
摘要:
Described are methods for stabilizing radionuclide-containing compositions against degradation caused by free radicals generated from the radionuclide. Iodide ions stabilize the radionuclide-containing compositions by acting as scavengers to generated free radicals, thus, preventing or lessening degradation therefrom. Among the preferred radionuclide-containing compositions to be stabilized are complexes of a complexing agent with a radionuclide complexed therewith, such as a diagnostic agent having a specific binding peptide linked to a metal ion-complexing moiety which is complexed with a radionuclide, such as technetium-99m (Tc-99m). Also included in the invention are compositions of radionuclide-containing compounds or complexes with iodide or an iodide ion-providing component, compositions of compounds or complexing agents that will be associated with a radionuclide and kits containing any combination of radionuclides, radionuclide generators, complexing agents or compounds which are associated with or will be associated with radionuclides and iodide or iodide-providing components.
摘要:
The present invention refers to a pharmaceutical composition applied to treat the Peyronie disease and the collagenous and fibrotic pathologies and its corresponding obtainment process. The composition comprises in its formulation papaine and eventually vitamin-E and/or hyaluronidase.
摘要:
The object of the present invention is to measure the silanol group concentration in silicon compound, rapidly and at a high accuracy by infrared spectrophotometry. A silicon compound, when comes in contact with, for example, water in the air, reacts therewith immediately, forming a silanol group. Therefore, in measurement of the silanol group concentration in silicon compound, it is necessary that the sample to be measured is not contacted with the air and that the very small amount of water adhering to the inside of a sample cell is removed completely. In the present invention, the removal of water inside the cell in a short time has been made possible by use of a pressure-resistant cell. The first aspect of the present invention lies in:
a method for measurement of silanol group concentration in silicon compound by infrared spectrophotometry, which comprises:
conducting, prior to filling of a silicon compound in a cell, at least twice each of a step of keeping the cell inside at 20 Pa or lower and a step of keeping the cell inside at 0.2 to 1 MPa, then, introducing the silicon compound into the cell and measuring the infrared absorption spectrum thereof, to measure the concentration of the silanol group in the silicon compound.
The second aspect of the present invention lies in:
a cell used for measurement of infrared absorption spectrum, which can withstand a reduced pressure of 20 Pa or lower and a pressure of 0.2 to 1 MPa.
摘要:
Die Erfindung betrifft neue Amidosulfamate von Estra-1,3,5(10)-trien-Derivaten, welche an der 3-Position eine R-SO 2 -O-Gruppe tragen, wobei R eine R 1 R 2 N-Gruppe oder R 1 NH-Gruppe ist, worin R 1 und R 2 unabhängig voneinander einen Alkylrest mit 1 - 5 C-Atomen oder zusammen mit dem N-Atom einen Polymethyleniminorest mit 4 bis 6 C-Atomen oder einen Morpholinorest bedeuten. Die erfindungsgemäßen Verbindungen sind zur hormonalen Kontrazeption und in der klimakterischen Hormon-Replacement-Therapie(HRT) sowie zur Behandlung gynäkologischer und andrologischer Krankheitsbilder geeignet. Daher weisen die erfindungsgemäßen Verbindungen nur eine geringe hepatische Estrogenität auf.
摘要:
The invention relates to a method for the production of 4-(17α substituted 3-oxoestra-4,9-dien-11β-yl)benzaldehyd-(1E or 1Z)-oximes of general formula (I), where R1 = H, C1-6 alkyl or a CnF2n+1 group; R2 = C1-4 alkyl, X = E- or Z-OH; and Y = O-C1-6 alkyl, S-C1-6 alkyl or O-CH2CnF2n+1, where n = 1, 2 or 3, which produces the target compounds of formula (I) with high yield and selectivity.
摘要:
The invention relates to a method for the production of 4-(17α-methyl substituted 3-oxoestra-4,9-dien-11β-yl)benzaldehyd-(1E or 1Z)-oximes of general formula (I), where R1 = H, C1-6 alkyl or a CnF2n+1 group, where n = 1, 2 or 3; R2 = C1-4 alkyl, X = E- or Z-OH; and Y = O-C1-6 alkyl, S-C1-6 alkyl or O-CH2CnF2n+1, where n = 1, 2 or 3, which produces the target compounds of formula (I) with high yield and selectivity.